The Latest Breaking News from Dynavax Technologies

A Relative Strength Rating upgrade for Dynavax Technologies shows improving technical performance.

Dynavax Technologies shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

Upgrades

Gainers

According to Benzinga Pro, during Q4, Dynavax Technologies (NASDAQ:DVAX) earned $99.78 million, a 450.96% increase from the preceding quarter. Dynavax Technologies also posted a total of $195.07 million in sales, a 80.17% increase since Q3.

Dynavax Technologies (NASDAQ:DVAX) reported its Q4 earnings results on Monday, February 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Dynavax Technologies sees its Relative Strength Rating move into the 80-plus level.

Dynavax Technologies (NASDAQ:DVAX) is set to give its latest quarterly earnings report on Monday, 2022-02-28. Here's what investors need to know before the announcement. Analysts estimate that Dynavax Technologies will report an earnings per share (EPS) of $0.69.